scholarly journals The 8th lung cancer TNM classification and clinical staging system: review of the changes and clinical implications

2018 ◽  
Vol 8 (7) ◽  
pp. 709-718 ◽  
Author(s):  
Wanyin Lim ◽  
Carole A. Ridge ◽  
Andrew G. Nicholson ◽  
Saeed Mirsadraee
Keyword(s):  
Lung Cancer ◽  
Tnm Classification ◽  
Staging System ◽  
Clinical Staging ◽  
Clinical Implications ◽  
System Review ◽  
Clinical Staging System

scholarly journals Japanese Clinical Staging System on TNM Classification for Lung Cancer

Haigan ◽  
1978 ◽  
Vol 18 (3) ◽  
pp. 293-300
Author(s):  
K. Yoshimura ◽  
N. Yamashita ◽  
S. Ishikawa
Keyword(s):  
Lung Cancer ◽  
Tnm Classification ◽  
Staging System ◽  
Clinical Staging ◽  
Clinical Staging System

scholarly journals Clinical Staging System on TNM Classification for Lung Cancer

Haigan ◽  
1975 ◽  
Vol 15 (4) ◽  
pp. 277-287
Author(s):  
K. Yoshimura ◽  
N. Yamashita ◽  
S. Ishikawa ◽  
A. Suzuki ◽  
T. Naruke
Keyword(s):  
Lung Cancer ◽  
Tnm Classification ◽  
Staging System ◽  
Clinical Staging ◽  
Clinical Staging System

Revision of the clinical staging system for cancer of the larynx

Cancer ◽  
1973 ◽  
Vol 31 (1) ◽  
pp. 72-80 ◽  
Author(s):  
Robert R. Smith ◽  
Ralph Caulk ◽  
Edgar Frazell ◽  
Paul H. Holinger ◽  
William S. Maccomb ◽  
...  
Keyword(s):  
Staging System ◽  
Clinical Staging ◽  
Clinical Staging System

A proposed clinical staging system for obesity

2009 ◽  
Vol 33 (3) ◽  
pp. 289-295 ◽  
Author(s):  
A M Sharma ◽  
R F Kushner
Keyword(s):  
Staging System ◽  
Clinical Staging ◽  
Clinical Staging System

A TNM-Based Clinical Staging System of Ocular Adnexal Lymphomas

2009 ◽  
Vol 133 (8) ◽  
pp. 1262-1267 ◽  
Author(s):  
Sarah E. Coupland ◽  
Valerie A. White ◽  
Jack Rootman ◽  
Bertil Damato ◽  
Paul T. Finger
Keyword(s):  
Prognostic Significance ◽  
Staging System ◽  
Clinical Staging ◽  
Disease Extent ◽  
Non Hodgkin Lymphoma ◽  
Ann Arbor ◽  
Data Points ◽  
Specific Factors ◽  
Clinical Staging System ◽  
User Friendly

Abstract Context.—The ocular adnexal lymphomas (OAL) arise in the conjunctiva, orbit, lacrimal gland, and eyelids. To date, they have been clinically staged using the Ann Arbor staging system, first designed for Hodgkin and later for nodal, non–Hodgkin lymphoma. The Ann Arbor system has several shortcomings, particularly when staging extranodal non– Hodgkin lymphomas, such as OAL, which show different dissemination patterns from nodal lymphomas. Objective.—To describe the first TNM-based clinical staging system for OAL. Design.—Retrospective literature review. Results.—We have developed, to our knowledge, the first American Joint Committee on Cancer–International Union Against Cancer TNM-based staging system for OAL to overcome the limitations of the Ann Arbor system. Our staging system defines disease extent more precisely within the various anatomic compartments of the ocular adnexa and allows for analysis of site-specific factors not addressed previously. It aims to facilitate future studies by identifying clinical and histomorphologic features of prognostic significance. This system is for primary OAL only and is not intended for intraocular lymphomas. Conclusions.—Our TNM-based staging system for OAL is a user-friendly, anatomic documentation of disease extent, which creates a common language for multicenter and international collaboration. Data points will be collected with the aim of identifying biomarkers to be incorporated into the staging system.

Sign in / Sign up

Export Citation Format

Share Document